A citation-based method for searching scientific literature

Su-Jin Kim, Cuilan Nian, Doris J Doudet, Christopher H S McIntosh. Diabetes 2009
Times Cited: 76



Jae Min Cho, Hye Won Jang, Hwanju Cheon, Yeon Taek Jeong, Do-Hoon Kim, Yu-Mi Lim, Song-Hyen Choi, Eun-Kyoung Yang, Chang-Yell Shin, Moon Ho Son, Soon Hoe Kim, Heung-Jae Kim, Myung-Shik Lee. Diabetes Res Clin Pract 2011
Times Cited: 40




List of shared articles



Times cited

Immunotherapeutic treatment of autoimmune diabetes.
Jae Hyeon Kim, Sang-Man Jin, Hun Sik Kim, Kyoung-Ah Kim, Myung-Shik Lee. Crit Rev Immunol 2013
2


The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic mice.
Jacob Jelsing, Niels Vrang, Søren B van Witteloostuijn, Michael Mark, Thomas Klein. J Endocrinol 2012
38

Role of dipeptidyl peptidase-4 inhibitors in new-onset diabetes after transplantation.
Sun Woo Lim, Ji Zhe Jin, Long Jin, Jian Jin, Can Li. Korean J Intern Med 2015
5

DPP-4 Inhibition Leads to Decreased Pancreatic Inflammatory Profile and Increased Frequency of Regulatory T Cells in Experimental Type 1 Diabetes.
Mariana Rodrigues Davanso, Carolina Caliari-Oliveira, Carlos Eduardo Barra Couri, Dimas Tadeu Covas, Angela Merice de Oliveira Leal, Júlio César Voltarelli, Kelen Cristina Ribeiro Malmegrim, Juliana Navarro Ueda Yaochite. Inflammation 2019
6


Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes.
Xia Wang, Peilin Zheng, Gan Huang, Lin Yang, Zhiguang Zhou. Clin Exp Med 2018
17

Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset.
Núria Alonso, María Teresa Julián, Jorge Carrascal, Roger Colobran, Irma Pujol-Autonell, Silvia Rodriguez-Fernández, Aina Teniente, Marco Antonio Fernández, Antoni Miñarro, María Carmen Ruiz de Villa,[...]. PLoS One 2015
7